The World Health Organization (WHO) recommends the Vi capsular polysaccharide vaccine for individuals living in or traveling to areas where typhoid fever is endemic. It is particularly important for school-aged children and those who are at higher risk of exposure, such as healthcare workers and laboratory staff. The vaccine is usually administered to individuals aged 2 years and older, as younger children may not respond as effectively to the polysaccharide antigen.
